1s9v
From Proteopedia
(New page: 200px<br /> <applet load="1s9v" size="450" color="white" frame="true" align="right" spinBox="true" caption="1s9v, resolution 2.22Å" /> '''Crystal structure o...) |
|||
Line 1: | Line 1: | ||
- | [[Image:1s9v. | + | [[Image:1s9v.jpg|left|200px]]<br /><applet load="1s9v" size="350" color="white" frame="true" align="right" spinBox="true" |
- | <applet load="1s9v" size=" | + | |
caption="1s9v, resolution 2.22Å" /> | caption="1s9v, resolution 2.22Å" /> | ||
'''Crystal structure of HLA-DQ2 complexed with deamidated gliadin peptide'''<br /> | '''Crystal structure of HLA-DQ2 complexed with deamidated gliadin peptide'''<br /> | ||
Line 8: | Line 7: | ||
==Disease== | ==Disease== | ||
- | Known diseases associated with this structure: Creutzfeldt-Jakob disease, variant, resistance to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604305 604305]], Multiple sclerosis, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604305 604305]] | + | Known diseases associated with this structure: Celiac disease, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=146880 146880]], Celiac disease, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604305 604305]], Creutzfeldt-Jakob disease, variant, resistance to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604305 604305]], Multiple sclerosis, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604305 604305]] |
==About this Structure== | ==About this Structure== | ||
- | 1S9V is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with EDO as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 1S9V is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=EDO:'>EDO</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1S9V OCA]. |
==Reference== | ==Reference== | ||
Line 26: | Line 25: | ||
[[Category: immune system]] | [[Category: immune system]] | ||
- | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:53:01 2008'' |
Revision as of 14:53, 15 February 2008
|
Crystal structure of HLA-DQ2 complexed with deamidated gliadin peptide
Contents |
Overview
Celiac disease, also known as celiac sprue, is a gluten-induced, autoimmune-like disorder of the small intestine, which is strongly, associated with HLA-DQ2. The structure of DQ2 complexed with an, immunogenic epitope from gluten, QLQPFPQPELPY, has been determined to, 2.2-A resolution by x-ray crystallography. The glutamate at P6, which is, formed by tissue transglutaminase-catalyzed deamidation, is an important, anchor residue as it participates in an extensive hydrogen-bonding network, involving Lys-beta71 of DQ2. The gluten peptide-DQ2 complex retains, critical hydrogen bonds between the MHC and the peptide backbone despite, the presence of many proline residues in the peptide that are unable to, participate in amide-mediated hydrogen bonds. Positioning of proline, residues such that they do not interfere with backbone hydrogen bonding, results in a reduction in the number of registers available for gluten, peptides to bind to MHC class II molecules and presumably impairs the, likelihood of establishing favorable side-chain interactions. The HLA, association in celiac disease can be explained by a superior ability of, DQ2 to bind the biased repertoire of proline-rich gluten peptides that, have survived gastrointestinal digestion and that have been deamidated by, tissue transglutaminase. Finally, surface-exposed proline residues in the, proteolytically resistant ligand were replaced with functionalized, analogs, thereby providing a starting point for the design of orally, active agents for blocking gluten-induced toxicity.
Disease
Known diseases associated with this structure: Celiac disease, susceptibility to OMIM:[146880], Celiac disease, susceptibility to OMIM:[604305], Creutzfeldt-Jakob disease, variant, resistance to OMIM:[604305], Multiple sclerosis, susceptibility to OMIM:[604305]
About this Structure
1S9V is a Protein complex structure of sequences from Homo sapiens with as ligand. Full crystallographic information is available from OCA.
Reference
Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease., Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM, Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4175-9. Epub 2004 Mar 12. PMID:15020763
Page seeded by OCA on Fri Feb 15 16:53:01 2008
Categories: Homo sapiens | Protein complex | Bergseng, E. | Khosla, C. | Kim, C.Y. | Quarsten, H. | Sollid, L.M. | EDO | Hla-dq2 | Immune system